A new informational resource concerning COVID-19 vaccine development, covidvaccinestatus.info, was recently launched to provide accurate and up-to-date information about ongoing, late-stage clinical trials of vaccines to prevent COVID-19. The website was developed by Susan Blalock, Ph.D., Professor Emeritus at the … Read more

The UNC Eshelman School of Pharmacy would like to send best wishes to professor Susan Blalock, Ph.D., MPH, who retired from the School on June 30. Blalock has worked for the University of North Carolina at Chapel Hill since 1982, … Read more

Jennifer Lafata, Ph.D., professor in the Division of Pharmaceutical Outcomes and Policy at the UNC Eshelman School of Pharmacy will take over as its vice chair upon the retirement of Susan Blalock, Ph.D., M.P.H, professor in DPOP and current vice … Read more

Giving patients hard numbers about the likelihood of experiencing side effects from a new medication makes them more likely to take the drug, according to a new study fromthe UNC Eshelman School of Pharmacy. Conversely, giving them similar information about … Read more

Professor Sue Blalock, Ph.D., M.P.H., has been appointed chairperson of the Food and Drug Administration’s Risk Communication Advisory Committee, effective until Sept. 30, 2018. She has been a member of the committee since 2013. Blalock is a professor in the … Read more

Rheumatoid arthritis is autoimmune disease that affects the entire body. People with RA are almost twice as likely as the average person to die from a heart attack and are nine times more likely to develop a serious lung disease. … Read more